Lenalidomide maintenance remains best for newly diagnosed MM

Phase III trials EMN441 (NCT01091831) and EMN01 (NCT01093196) both investigated progression-free survival (PFS), overall survival (OS) and time to next treatment, in newly diagnosed multiple myeloma (... Author: VJHemOnc Added: 07/18/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts